Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986 Aug;78(2):448-55.
doi: 10.1172/JCI112596.

Verapamil favorably influences hepatic microvascular exchange and function in rats with cirrhosis of the liver

Verapamil favorably influences hepatic microvascular exchange and function in rats with cirrhosis of the liver

J Reichen et al. J Clin Invest. 1986 Aug.

Abstract

The effect of the calcium channel blocking agent, verapamil, on microcirculatory patterns and hepatic function was investigated in the perfused liver of cirrhotic rats. Compared with controls, cirrhotic livers had higher vascular resistance, increased intrahepatic shunting, and smaller extravascular albumin space and larger extravascular sucrose space, as determined by a multiple-indicator dilution technique. Hepatic function, estimated by determining propranolol and antipyrine extraction, was markedly reduced in cirrhotic livers. Portal pressure was then reduced 25% either pharmacologically by verapamil or hydrodynamically by lowering inflow. Verapamil decreased vascular resistance by 22%. This was associated with a 38% reduction in intrahepatic shunting and a 62% increase in extravascular albumin space. Hydrodynamically lowering pressure had no or adverse effects. The verapamil-induced improvement in microcirculatory characteristics was associated with a significant improvement in oxygen consumption (+21%) and antipyrine clearance (+20%). We conclude that the microvascular distortions of liver cirrhosis in the rat are partially reversible by vasodilators like verapamil.

PubMed Disclaimer

References

    1. Br J Exp Pathol. 1969 Oct;50(5):502-6 - PubMed
    1. J Pharmacol Exp Ther. 1950 Jan;98(1):97-104 - PubMed
    1. Circ Res. 1970 Nov;27(5):739-64 - PubMed
    1. J Pharmacol Exp Ther. 1973 Sep;186(3):447-54 - PubMed
    1. J Pharmacokinet Biopharm. 1973 Apr;1(2):123-36 - PubMed

Publication types

MeSH terms